Speakers

• He received his PhD in human genetics from Tel-Aviv University working on hereditary hearing loss.
• He then did his postdoc, specializing in functional genomics, in the Lawrence Berkeley National Laboratory and the DOE Joint Genome Institute.
• His current work is focused on identifying gene regulatory elements and linking nucleotide variation within them to various phenotypes including morphological differences between species, drug response and human disease.
• His lab was one of the co-developers of massively parallel reporter assays (MPRAs) that allow for high-throughput functional characterization of gene regulatory elements.
• In addition, he pioneered cis-regulation therapy (CRT), the use of gene regulatory elements as therapeutic targets for haploinsufficient disorders, and adipose modulation transplantation (AMT), a novel cancer cell therapy.

Areas of special interest

• Functional genomics & translational medicine
• Human genetics & disease
• Gene regulatory elements
• Nucleotide variation & phenotypes